Guidelines for the first-line treatment of restless legs syndrome/Willis–Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation

•Prevention of augmentation may be started by considering using medications such as α2δ ligands for initial RLS treatment.•If treatment is initiated with dopaminergic drugs, the dose should be kept low and not exceed that recommended for RLS.•Patients with low iron stores should be given appropriate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Sleep medicine Jg. 21; S. 1 - 11
Hauptverfasser:	Garcia-Borreguero, Diego, Silber, Michael H., Winkelman, John W., Högl, Birgit, Bainbridge, Jacquelyn, Buchfuhrer, Mark, Hadjigeorgiou, Georgios, Inoue, Yuichi, Manconi, Mauro, Oertel, Wolfgang, Ondo, William, Winkelmann, Juliane, Allen, Richard P.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Netherlands Elsevier B.V 01.05.2016
Schlagworte:	Algorithm Alpha 2 delta ligands Augmentation Consensus Dopamine agents Dopamine Agonists - adverse effects Dopamine Agonists - therapeutic use Drug Synergism Evidence-Based Medicine Humans Neurology Practice Guidelines as Topic Prevention Restless legs syndrome Restless Legs Syndrome - drug therapy Sleep Medicine Augmentation Prevention Restless legs syndrome Dopamine agents Alpha 2 delta ligands Algorithm
ISSN:	1389-9457, 1878-5506, 1878-5506
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!